NCT02461433

Brief Summary

The purpose of this study is to determine whether application of an incisional wound Prevena trademark (TM) dressing (applies negative pressure to wounds) in the obese (BMI ≥30) surgical patient will reduce surgical site infections (SSI) when compared to the standard of care dressing.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2015

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
12 months until next milestone

Results Posted

Study results publicly available

February 12, 2018

Completed
Last Updated

February 26, 2019

Status Verified

February 1, 2019

Enrollment Period

1.8 years

First QC Date

June 1, 2015

Results QC Date

October 5, 2017

Last Update Submit

February 7, 2019

Conditions

Keywords

ObesityObesesurgical site infectionclosed incisionsnegative pressure therapy

Outcome Measures

Primary Outcomes (1)

  • Surgical Site Infection According to National Healthcare Safety Network - Center for Disease Control Guidelines

    The incidence of postoperative surgical site infection (according to National Healthcare Safety Network - Center for Disease Control guidelines) in open surgery

    Up to 7 days postop

Secondary Outcomes (10)

  • Other Wound Complications (Aggregate)

    Up to 14 days postop

  • Skin Bacterial Count as Assessed by Microbacterial Count

    Up to 7 days postop

  • Physical Function as Assessed by Short Form Survey (SF) 36

    Up to 14 days postop

  • Readmissions

    Up to 30 days postop

  • Role Limitations Due to Physical Health as Assessed by Short Form Survey (SF) 36

    Up to 14 days postop

  • +5 more secondary outcomes

Study Arms (2)

Prevena

EXPERIMENTAL

After surgery this group will receive the Prevena device (negative pressure wound therapy).

Device: Prevena

Standard dressing

ACTIVE COMPARATOR

After surgery this group will receive standard of care dressings on their surgical wound.

Device: Standard Dressing

Interventions

PrevenaDEVICE

Prevena Incision Management system

Prevena

This involves standard of care dressing including but not limited to gauze.

Standard dressing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient has been informed of the nature of the study, and has provided written informed consent, approved by the appropriate Institutional Review Board (IRB) / Medical Ethics Committee (MEC) of the respective clinical site.
  • Patient meets the criteria for and is undergoing open surgery at Johns Hopkins Medical Institutes.
  • Patient with BMI≥ 30 at the time of surgery
  • Patient agrees to return for all required clinical follow up for the study.

You may not qualify if:

  • Known allergic reaction to acrylic adhesives or silver.
  • Known history of intolerance to any component of Prevena Incision Management System TM.
  • Very fragile skin around incision site.
  • Bleeding disorder or refuses blood transfusion.
  • Malignancy or other condition limiting life expectancy to \<5 years.
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Medical Institutes

Baltimore, Maryland, 21287, United States

Location

MeSH Terms

Conditions

Surgical Wound InfectionObesityPostoperative Complications

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPathologic ProcessesPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and Symptoms

Results Point of Contact

Title
Mahmoud Malas
Organization
Johns Hopkins University

Study Officials

  • Kimberley Steele, MD, PHD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 1, 2015

First Posted

June 3, 2015

Study Start

June 1, 2015

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

February 26, 2019

Results First Posted

February 12, 2018

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations